Mingteng International Corp Inc. (MTEN) — Institutional Holders, Q4 2025
3 institutional investment managers reported a MTEN position on SEC Form 13F-HR for the quarter ended December 31, 2025, with a combined reported value of $35.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MTEN in Q4 2025: what funds did
Funds that filed a 13F for both Q3 2025 and Q4 2025, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- XTX Topco LtdNew · +26,356 sh+$22.0K
- JANE STREET GROUPNew · +15,048 sh+$12.6K
- OSAICNew · +800 sh+$668.00
Biggest sellers
- UBS Group AGSold out · -1,828 sh-$1.5K
- BNP PARIBAS FINANCIAL MARKETSSold out · -1,200 sh-$1.0K
MTEN 13F holders ranked 1–3 of 3
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q3 2025 |
|---|---|---|---|---|---|
| 1 | XTX Topco Ltd#1 · 26,356 sh | 26,356 | $22.0K | — | New |
| 2 | JANE STREET GROUP#2 · 15,048 sh | 15,048 | $12.6K | — | New |
| 3 | OSAIC#3 · 800 sh | 800 | $672.00 | — | New |
Funds that sold out of MTEN in Q4 2025 (2)
Held MTEN at the end of Q3 2025 and filed a Q4 2025 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q3 2025 |
|---|---|---|
| UBS Group AG1,828 sh | 1,828 | $11.6K |
| BNP PARIBAS FINANCIAL MARKETS1,200 sh | 1,200 | $7.6K |
Source: Form 13F-HR filings on SEC EDGAR, Q4 2025. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q3 2025 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.